Financhill
Back

Stereotaxis, Inc. 10K Form

Sell
21

STXS
Stereotaxis, Inc.

Last Price:
$1.89
Seasonality Move:
-6.65%

7 Day Trial

ALL ACCESS PASS

$ 7

Key Filings

10K form not available

Receive STXS News And Ratings

See the #1 stock for the next 7 days that we like better than STXS

STXS Financial Statistics

Sales & Book Value

Annual Sales: $32.4M
Cash Flow: $-4M
Price / Cash Flow: 0
Annual Sales: $0.14
Price / Book: 13.78

Profitability

EPS (TTM): -0.25170
Net Income (TTM): $-21.6M
Gross Margin: $17.1M
Return on Equity: -191.14%
Return on Assets: -46.76%

Stereotaxis, Inc. Earnings Forecast

Key Stereotaxis, Inc. Financial Ratios

  • The Gross Profit Margin over the past 26 years for STXS is 52.73%.
  • The Selling, General & Administrative Expenses for STXS have been equal to 93.56% of Gross Profit Margin.
  • The Research & Development expenses have been 28.98% of Revenue.
  • The Net Earning history of STXS is -66.85% of Total Revenues.
  • Per Share Earnings over the last 26 years have been positive in 14 years.

Stereotaxis, Inc. Stock Price Chart

Industry, Sector and Symbol

Stock Exchange: NYAM
Industry: Health Care Equipment & Supplies
Sector: Health Care
Current Symbol: STXS
CUSIP: 85916J
Website: stereotaxis.com

Debt

Debt-to-Equity Ratio: 0.29
Current Ratio: 1.51
Quick Ratio: 0.89

Price-to-Earnings

Trailing P/E Ratio: 0
Forward P/E Ratio: 0

STXS Technical Analysis vs Fundamental Analysis

Sell
21
Stereotaxis, Inc. (STXS) is a Sell

Is Stereotaxis, Inc. a Buy or a Sell?

  • Stereotaxis, Inc. stock is rated a Sell
    The current Stereotaxis, Inc. [STXS] share price is $1.87. The Score for STXS is 21, which is 58% below its historic median score of 50, and infers higher risk than normal.